fda ruling on tirzepatide Compounders lose battle over Eli Lilly weight loss drug and shortage list Tirzepatide is NO longer in

Possible side effects may include nausea, vomiting, diarrhea, constipation, abdominal discomfort, appetite changes, or other symptoms

Read: User reviews mentioning nausea and vomiting Diarrhea Diarrhea affected 19% to 23% of people in weight-management studies of tirzepatide, compared with 8% on placebo

Thus, it is recommended to investigate for this AE in SGLT2i-treated patients with symptoms of ketoacidosis, such as nausea, vomiting, abdominal pain, ketonuria, and/or ketonemia, regardless of the current glucose status [74]

Some people with MASLD may develop MASH

Ozempic is a newer option that increases production of insulin and slows gastric emptying